CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19

Saeedeh Ebrahimi; Hashem Khanbabaei; Samaneh Abbasi; Mona Fani; Saber Soltani; Milad Zandi; Zahra Najafimemar

doi:10.18502/ajmb.v14i1.8165

CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19

Avicenna J Med Biotechnol. 2022 Jan-Mar;14(1):3-9. doi: 10.18502/ajmb.v14i1.8165.

Authors

Saeedeh Ebrahimi¹, Hashem Khanbabaei², Samaneh Abbasi³, Mona Fani⁴, Saber Soltani⁵, Milad Zandi⁵, Zahra Najafimemar⁶

Affiliations

¹ Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
² Department of Radiologic Technology, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran.
³ Abadan University of Medical Sciences, Abadan, Iran.
⁴ Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
⁵ Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
⁶ Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Abstract

More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.

Keywords: COVID-19; CRISPR-Cas systems; SARS-CoV-2.

Publication types

Review